SCHEMBL18968950

SCHEMBL18968950

CC1(C)c2cccc3c2-c2c1cccc2C3(c1ccccc1)c1ccc(-c2ccc(N(c3ccc(-c4cccc5ccccc45)cc3)c3ccc(-c4cccc5ccccc45)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.36
▸ CA1 P00915 3/20 0.36
▸ CA2 P00918 3/20 0.36
▸ CA9 Q16790 3/20 0.36
▸ CHRNB4 P30926 2/20 0.36
▸ CHRNA3 P32297 2/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ PPARG P37231 8/20 0.35
▸ PPARA Q07869 8/20 0.35
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ PPARD Q03181 1/20 0.34
▸ CHRNA1 P02708 1/20 0.34
▸ CHRNG P07510 1/20 0.34
▸ CHRNB1 P11230 1/20 0.34
▸ CHRNB2 P17787 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ CHRNA4 P43681 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18968933 0.99 CHRNB4 (0.36) CA12CA1CA2CA9CHRNB4
SCHEMBL18968937 0.99 CHRNB4 (0.36) CA12CA1CA2CA9CHRNB4
SCHEMBL18968938 0.99 CHRNB4 (0.36) CA12CA1CA2CA9CHRNB4
SCHEMBL18969086 0.94 CHRNB4 (0.34) CA12CA1CA2CA9CHRNB4
SCHEMBL18968920 0.93 CHRNB4 (0.39) CA12CA1CA2CA9CHRNB4
SCHEMBL18968919 0.93 CHRNB4 (0.39) CA12CA1CA2CA9CHRNB4
SCHEMBL18968940 0.93 CHRNB4 (0.34) CA12CA1CA2CA9CHRNB4
SCHEMBL18968927 0.92 CHRNB4 (0.36) CA12CA1CA2CA9CHRNB4
SCHEMBL18968941 0.92 CHRNB4 (0.35) CA12CA1CA2CA9CHRNB4
SCHEMBL18968926 0.88 CHRNB4 (0.37) CA12CA1CA2CA9CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361374-B2 Amine compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-23 — — US disclosed
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-15 — — US disclosed
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOC2, MAOA, AOC3 CA12 4774/4885CA1 4678/4885CA2 4731/4885
US-10361374-B2 Amine compound and organic light emitting device including the same AOC2, MAOA, AOC3 CA12 4774/4885CA1 4678/4885CA2 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback